Combining Chimeric Mice with Humanized Liver, Mass Spectrometry, and Physiologically-Based Pharmacokinetic Modeling in Toxicology. 2016

Hiroshi Yamazaki, and Hiroshi Suemizu, and Marina Mitsui, and Makiko Shimizu, and F Peter Guengerich
Showa Pharmaceutical University , Machida, Tokyo 194-8543, Japan.

Species differences exist in terms of drug oxidation activities, which are mediated mainly by cytochrome P450 (P450) enzymes. To overcome the problem of species extrapolation, transchromosomic mice containing a human P450 3A cluster or chimeric mice transplanted with human hepatocytes have been introduced into the human toxicology research area. In this review, drug metabolism and disposition mediated by humanized livers in chimeric mice are summarized in terms of biliary/urinary excretions of phthalate and bisphenol A and plasma clearances of the human cocktail probe drugs caffeine, warfarin, omeprazole, metoprolol, and midazolam. Simulation of human plasma concentrations of the teratogen thalidomide and its human metabolites is possible with a simplified physiologically based pharmacokinetic model based on data obtained in chimeric mice, in accordance with reported clinical thalidomide concentrations. In addition, in vivo nonspecific hepatic protein binding parameters of metabolically activated 14C-drug candidate and hepatotoxic medicines in humanized liver mice can be analyzed by accelerator mass spectrometry and are useful for predictions in humans.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D002678 Chimera An individual that contains cell populations derived from different zygotes. Hybrids,Chimeras,Hybrid
D003577 Cytochrome P-450 Enzyme System A superfamily of hundreds of closely related HEMEPROTEINS found throughout the phylogenetic spectrum, from animals, plants, fungi, to bacteria. They include numerous complex monooxygenases (MIXED FUNCTION OXYGENASES). In animals, these P-450 enzymes serve two major functions: (1) biosynthesis of steroids, fatty acids, and bile acids; (2) metabolism of endogenous and a wide variety of exogenous substrates, such as toxins and drugs (BIOTRANSFORMATION). They are classified, according to their sequence similarities rather than functions, into CYP gene families (>40% homology) and subfamilies (>59% homology). For example, enzymes from the CYP1, CYP2, and CYP3 gene families are responsible for most drug metabolism. Cytochrome P-450,Cytochrome P-450 Enzyme,Cytochrome P-450-Dependent Monooxygenase,P-450 Enzyme,P450 Enzyme,CYP450 Family,CYP450 Superfamily,Cytochrome P-450 Enzymes,Cytochrome P-450 Families,Cytochrome P-450 Monooxygenase,Cytochrome P-450 Oxygenase,Cytochrome P-450 Superfamily,Cytochrome P450,Cytochrome P450 Superfamily,Cytochrome p450 Families,P-450 Enzymes,P450 Enzymes,Cytochrome P 450,Cytochrome P 450 Dependent Monooxygenase,Cytochrome P 450 Enzyme,Cytochrome P 450 Enzyme System,Cytochrome P 450 Enzymes,Cytochrome P 450 Families,Cytochrome P 450 Monooxygenase,Cytochrome P 450 Oxygenase,Cytochrome P 450 Superfamily,Enzyme, Cytochrome P-450,Enzyme, P-450,Enzyme, P450,Enzymes, Cytochrome P-450,Enzymes, P-450,Enzymes, P450,Monooxygenase, Cytochrome P-450,Monooxygenase, Cytochrome P-450-Dependent,P 450 Enzyme,P 450 Enzymes,P-450 Enzyme, Cytochrome,P-450 Enzymes, Cytochrome,Superfamily, CYP450,Superfamily, Cytochrome P-450,Superfamily, Cytochrome P450
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass
D013792 Thalidomide A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action. Sedoval,Thalomid
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D065767 Activation, Metabolic The conversion of an exogenous substance by a biological system resulting in the production on an active metabolite. Metabolic Activation,Drug Activation,Activation, Drug
D066007 Toxicokinetics The quantitation of the body's metabolism of toxic xenobiotic compounds, as measured by the plasma concentration of the toxicant at various time points.

Related Publications

Hiroshi Yamazaki, and Hiroshi Suemizu, and Marina Mitsui, and Makiko Shimizu, and F Peter Guengerich
March 2022, Toxicology and applied pharmacology,
Hiroshi Yamazaki, and Hiroshi Suemizu, and Marina Mitsui, and Makiko Shimizu, and F Peter Guengerich
April 2008, Toxicology,
Hiroshi Yamazaki, and Hiroshi Suemizu, and Marina Mitsui, and Makiko Shimizu, and F Peter Guengerich
August 1994, Risk analysis : an official publication of the Society for Risk Analysis,
Hiroshi Yamazaki, and Hiroshi Suemizu, and Marina Mitsui, and Makiko Shimizu, and F Peter Guengerich
April 2019, Xenobiotica; the fate of foreign compounds in biological systems,
Hiroshi Yamazaki, and Hiroshi Suemizu, and Marina Mitsui, and Makiko Shimizu, and F Peter Guengerich
January 2012, Methods in molecular biology (Clifton, N.J.),
Hiroshi Yamazaki, and Hiroshi Suemizu, and Marina Mitsui, and Makiko Shimizu, and F Peter Guengerich
November 2009, Drug testing and analysis,
Hiroshi Yamazaki, and Hiroshi Suemizu, and Marina Mitsui, and Makiko Shimizu, and F Peter Guengerich
May 2011, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology,
Hiroshi Yamazaki, and Hiroshi Suemizu, and Marina Mitsui, and Makiko Shimizu, and F Peter Guengerich
July 2008, Toxicological sciences : an official journal of the Society of Toxicology,
Hiroshi Yamazaki, and Hiroshi Suemizu, and Marina Mitsui, and Makiko Shimizu, and F Peter Guengerich
January 2008, Toxicological sciences : an official journal of the Society of Toxicology,
Hiroshi Yamazaki, and Hiroshi Suemizu, and Marina Mitsui, and Makiko Shimizu, and F Peter Guengerich
January 2019, Journal of pharmaceutical sciences,
Copied contents to your clipboard!